BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mclean MH, El-omar EM. Genetics of gastric cancer. Nat Rev Gastroenterol Hepatol 2014;11:664-74. [DOI: 10.1038/nrgastro.2014.143] [Cited by in Crossref: 222] [Cited by in F6Publishing: 216] [Article Influence: 27.8] [Reference Citation Analysis]
Number Citing Articles
1 Ciesielski M, Szajewski M, Walczak J, Pęksa R, Lenckowski R, Supeł M, Zieliński J, Kruszewski WJ. Impact of chromosome 17 centromere copy number increase on patient survival and human epidermal growth factor receptor 2 expression in gastric adenocarcinoma. Oncol Lett 2021;21:142. [PMID: 33552261 DOI: 10.3892/ol.2020.12403] [Reference Citation Analysis]
2 Alikhani R, Taravati A, Hashemi-Soteh MB. Association of MUC1 5640G>A and PSCA 5057C>T polymorphisms with the risk of gastric cancer in Northern Iran. BMC Med Genet 2020;21:148. [PMID: 32660489 DOI: 10.1186/s12881-020-01085-z] [Reference Citation Analysis]
3 Beikzadeh B, Angaji SA, Abolhasani M. Association study between common variations in some candidate genes and prostate adenocarcinoma predisposition through multi-stage approach in Iranian population. BMC Med Genet 2020;21:81. [PMID: 32295536 DOI: 10.1186/s12881-020-01014-0] [Reference Citation Analysis]
4 Avcı N, Ture M, Deligonul A, Cubukcu E, Olmez OF, Sahinturk S, Topak A, Kurt E, Evrensel T, Şahin AB, Yakut T. Association and Prognostic Significance of the Functional -1562C/T Polymorphism in the Promoter Region of MMP-9 in Turkish Patients with Gastric Cancer. Pathol Oncol Res 2015;21:1243-7. [PMID: 26156886 DOI: 10.1007/s12253-015-9950-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
5 Varkalaite G, Vaitkeviciute E, Inciuraite R, Salteniene V, Juzenas S, Petkevicius V, Gudaityte R, Mickevicius A, Link A, Kupcinskas L, Leja M, Kupcinskas J, Skieceviciene J. Atrophic gastritis and gastric cancer tissue miRNome analysis reveals hsa-miR-129-1 and hsa-miR-196a as potential early diagnostic biomarkers. World J Gastroenterol 2022; 28(6): 653-663 [DOI: 10.3748/wjg.v28.i6.653] [Reference Citation Analysis]
6 Gulley ML. Genomic assays for Epstein-Barr virus-positive gastric adenocarcinoma. Exp Mol Med. 2015;47:e134. [PMID: 25613731 DOI: 10.1038/emm.2014.93] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 6.3] [Reference Citation Analysis]
7 Liu C, Ren L, Wang Y, Liu Y, Xiao J. The interaction between RACK1 and WEE1 regulates the growth of gastric cancer cell line HGC27. Oncol Lett 2017;14:4784-92. [PMID: 29085480 DOI: 10.3892/ol.2017.6741] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
8 Zhu M, Wang Y, Liu X, Wen X, Liang C, Tu J. LncRNAs act as prognostic biomarkers in gastric cancer: A systematic review and meta-analysis. Frontiers in Laboratory Medicine 2017;1:59-68. [DOI: 10.1016/j.flm.2017.05.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
9 Giordano A, Tommonaro G. Curcumin and Cancer. Nutrients 2019;11:E2376. [PMID: 31590362 DOI: 10.3390/nu11102376] [Cited by in Crossref: 120] [Cited by in F6Publishing: 95] [Article Influence: 40.0] [Reference Citation Analysis]
10 Gantuya B, Bolor D, Oyuntsetseg K, Erdene-Ochir Y, Sanduijav R, Davaadorj D, Tserentogtokh T, Azzaya D, Uchida T, Matsuhisa T, Yamaoka Y. New observations regarding Helicobacter pylori and gastric cancer in Mongolia. Helicobacter 2018;23:e12491. [PMID: 29882322 DOI: 10.1111/hel.12491] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
11 Han X, Chen Y, Yao N, Liu H, Wang Z. MicroRNA let-7b suppresses human gastric cancer malignancy by targeting ING1. Cancer Gene Ther. 2015;22:122-129. [PMID: 25613480 DOI: 10.1038/cgt.2014.75] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
12 Chen H, Xu L, Shan ZL, Chen S, Hu H. GPX8 is transcriptionally regulated by FOXC1 and promotes the growth of gastric cancer cells through activating the Wnt signaling pathway. Cancer Cell Int 2020;20:596. [PMID: 33317536 DOI: 10.1186/s12935-020-01692-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Yin X, Lin H, Lin L, Miao L, He J, Zhuo Z. LncRNAs and CircRNAs in cancer. MedComm 2022;3. [DOI: 10.1002/mco2.141] [Reference Citation Analysis]
14 Ma L, Zhang D, Huang Z, Zheng R, Du M, Lv Q, Qin C, Chu H, Yuan L, Zhang Z. Functional variants of RPS6KB1 and PIK3R1 in the autophagy pathway genes and risk of bladder cancer. Arch Toxicol 2021. [PMID: 34668023 DOI: 10.1007/s00204-021-03173-2] [Reference Citation Analysis]
15 Wu Q, Ma J, Wei J, Meng W, Wang Y, Shi M. FOXD1-AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway. Mol Oncol 2021;15:299-316. [PMID: 32460412 DOI: 10.1002/1878-0261.12728] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
16 Kanda M, Shimizu D, Fujii T, Tanaka H, Tanaka Y, Ezaka K, Shibata M, Takami H, Hashimoto R, Sueoka S. Neurotrophin Receptor-interacting Melanoma Antigen-encoding Gene Homolog Is Associated with Malignant Phenotype of Gastric Cancer. Ann Surg Oncol. 2016; Epub ahead of print. [PMID: 27364510 DOI: 10.1245/s10434-016-5375-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
17 Ghafouri-Fard S, Honarmand Tamizkar K, Jamali E, Taheri M, Ayatollahi SA. Contribution of circRNAs in gastric cancer. Pathol Res Pract 2021;227:153640. [PMID: 34624593 DOI: 10.1016/j.prp.2021.153640] [Reference Citation Analysis]
18 Mesic A, Rogar M, Hudler P, Bilalovic N, Eminovic I, Komel R. Genetic variations in AURORA cell cycle kinases are associated with glioblastoma multiforme. Sci Rep 2021;11:17444. [PMID: 34465813 DOI: 10.1038/s41598-021-96935-y] [Reference Citation Analysis]
19 Singh K, Gandhi S, Batool R. A Case-Control Study of the Association between Vitamin D Levels and Gastric Incomplete Intestinal Metaplasia. Nutrients 2018;10:E629. [PMID: 29772698 DOI: 10.3390/nu10050629] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
20 Sultana Z, Bankura B, Pattanayak AK, Sengupta D, Sengupta M, Saha ML, Panda CK, Das M. Association of Interleukin-1 beta and tumor necrosis factor-alpha genetic polymorphisms with gastric cancer in India. Environ Mol Mutagen 2018;59:653-67. [PMID: 30094865 DOI: 10.1002/em.22208] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
21 Yu B, Gu D, Zhang X, Liu B, Xie J. The role of GLI2-ABCG2 signaling axis for 5Fu resistance in gastric cancer. J Genet Genomics 2017;44:375-83. [PMID: 28847472 DOI: 10.1016/j.jgg.2017.04.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
22 Kang BW, Kim JG, Lee IH, Bae HI, Seo AN. Clinical significance of tumor-infiltrating lymphocytes for gastric cancer in the era of immunology. World J Gastrointest Oncol 2017; 9(7): 293-299 [PMID: 28808502 DOI: 10.4251/wjgo.v9.i7.293] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
23 Gong H, Li H, Zou J, Mi J, Liu F, Wang D, Yan D, Wang B, Zhang S, Tian G. The relationship between five non-synonymous polymorphisms within three XRCC genes and gastric cancer risk in a Han Chinese population. Tumor Biol 2016;37:5905-10. [DOI: 10.1007/s13277-015-3502-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
24 Riquelme I, Saavedra K, Espinoza JA, Weber H, García P, Nervi B, Garrido M, Corvalán AH, Roa JC, Bizama C. Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy. Oncotarget 2015;6:24750-79. [PMID: 26267324 DOI: 10.18632/oncotarget.4990] [Cited by in Crossref: 78] [Cited by in F6Publishing: 71] [Article Influence: 13.0] [Reference Citation Analysis]
25 Liu Y, Zhang X, Zhang Y, Hu Z, Yang D, Wang C, Guo M, Cai Q. Identification of miRNomes in human stomach and gastric carcinoma reveals miR-133b/a-3p as therapeutic target for gastric cancer. Cancer Lett 2015;369:58-66. [PMID: 26276722 DOI: 10.1016/j.canlet.2015.06.028] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
26 Li Q, Qu F, Li R, He X, Zhai Y, Chen W, Zheng Y. A functional polymorphism of SSBP1 gene predicts prognosis and response to chemotherapy in resected gastric cancer patients. Oncotarget 2017;8:110861-76. [PMID: 29340022 DOI: 10.18632/oncotarget.22864] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
27 Maués JHDS, Ribeiro HF, Pinto GR, Lopes LO, Lamarão LM, Pessoa CMF, Moreira-Nunes CFA, de Carvalho RM, Assumpção PP, Rey JA, Burbano RMR. Gastric Cancer Cell Lines Have Different MYC-Regulated Expression Patterns but Share a Common Core of Altered Genes. Can J Gastroenterol Hepatol 2018;2018:5804376. [PMID: 30410872 DOI: 10.1155/2018/5804376] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
28 Jafarzadeh M, Soltani BM. Long Noncoding RNA LOC400043 (LINC02381) Inhibits Gastric Cancer Progression Through Regulating Wnt Signaling Pathway. Front Oncol 2020;10:562253. [PMID: 33194632 DOI: 10.3389/fonc.2020.562253] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
29 Tanikawa C, Kamatani Y, Toyoshima O, Sakamoto H, Ito H, Takahashi A, Momozawa Y, Hirata M, Fuse N, Takai-Igarashi T, Shimizu A, Sasaki M, Yamaji T, Sawada N, Iwasaki M, Tsugane S, Naito M, Hishida A, Wakai K, Furusyo N, Murakami Y, Nakamura Y, Imoto I, Inazawa J, Oze I, Sato N, Tanioka F, Sugimura H, Hirose H, Yoshida T, Matsuo K, Kubo M, Matsuda K. Genome-wide association study identifies gastric cancer susceptibility loci at 12q24.11-12 and 20q11.21. Cancer Sci 2018;109:4015-24. [PMID: 30281874 DOI: 10.1111/cas.13815] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
30 Trejo-de la OA, Torres J, Sánchez-Zauco N, Pérez-Rodríguez M, Camorlinga-Ponce M, Flores-Luna L, Lazcano-Ponce E, Maldonado-Bernal C. Polymorphisms in TLR9 but not in TLR5 increase the risk for duodenal ulcer and alter cytokine expression in the gastric mucosa. Innate Immun. 2015;21:706-713. [PMID: 25995217 DOI: 10.1177/1753425915587130] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
31 Jin T, Cao W, Zuo X, Li M, Yang Y, Liang T, Yang H, Zhao X, Yang D. IL-1RN gene polymorphisms are associated with breast cancer risk in a Chinese Han population. J Gene Med 2017;19:e2996. [DOI: 10.1002/jgm.2996] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
32 Yamamoto H, Watanabe Y, Oikawa R, Morita R, Yoshida Y, Maehata T, Yasuda H, Itoh F. BARHL2 Methylation Using Gastric Wash DNA or Gastric Juice Exosomal DNA is a Useful Marker For Early Detection of Gastric Cancer in an H. pylori-Independent Manner. Clin Transl Gastroenterol. 2016;7:e184. [PMID: 27441821 DOI: 10.1038/ctg.2016.40] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 5.7] [Reference Citation Analysis]
33 Chen Z, Li Z, Soutto M, Wang W, Piazuelo MB, Zhu S, Guo Y, Maturana MJ, Corvalan AH, Chen X, Xu Z, El-Rifai WM. Integrated Analysis of Mouse and Human Gastric Neoplasms Identifies Conserved microRNA Networks in Gastric Carcinogenesis. Gastroenterology 2019;156:1127-1139.e8. [PMID: 30502323 DOI: 10.1053/j.gastro.2018.11.052] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
34 Nanbo A, Ohashi M, Yoshiyama H, Ohba Y. The Role of Transforming Growth Factor β in Cell-to-Cell Contact-Mediated Epstein-Barr Virus Transmission. Front Microbiol 2018;9:984. [PMID: 29867885 DOI: 10.3389/fmicb.2018.00984] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
35 Huang YS, Jie N, Zou KJ, Weng Y. Expression profile of circular RNAs in human gastric cancer tissues. Mol Med Rep. 2017;16:2469-2476. [PMID: 28737829 DOI: 10.3892/mmr.2017.6916] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 6.4] [Reference Citation Analysis]
36 Li Y, Sun H, Guan J, Ji T, Wang X. Serum microRNA-381: A Potential Marker for Early Diagnosis of Gastric Cancer. Yonsei Med J 2019;60:720-6. [PMID: 31347326 DOI: 10.3349/ymj.2019.60.8.720] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
37 Li J, Pu K, Li C, Wang Y, Zhou Y. A Novel Six-Gene-Based Prognostic Model Predicts Survival and Clinical Risk Score for Gastric Cancer. Front Genet 2021;12:615834. [PMID: 33692828 DOI: 10.3389/fgene.2021.615834] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Song Z, Guo C, Zhu L, Shen P, Wang H, Guo C, Tang J. Elevated expression of immunity-related GTPase family M in gastric cancer. Tumor Biol 2015;36:5591-6. [DOI: 10.1007/s13277-015-3229-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
39 Yu SY, Hou XL, Duan XW, Yan HZ, Liu W, Tang J. Significance of expression of HDAC1 protein in gastric cancer. Shijie Huaren Xiaohua Zazhi 2015; 23(33): 5290-5295 [DOI: 10.11569/wcjd.v23.i33.5290] [Cited by in CrossRef: 2] [Article Influence: 0.3] [Reference Citation Analysis]
40 Choi YJ, Kim N. Gastric cancer and family history. Korean J Intern Med. 2016;31:1042-1053. [PMID: 27809451 DOI: 10.3904/kjim.2016.147] [Cited by in Crossref: 65] [Cited by in F6Publishing: 53] [Article Influence: 10.8] [Reference Citation Analysis]
41 Wang N, Qiao Q, Bao G, Wu T, Li Y, Li J, Lu J, He X. Genetic polymorphisms are associated with the risk of gastric and colorectal cancers in a Han Chinese population. Oncotarget 2017;8:28805-11. [PMID: 28404937 DOI: 10.18632/oncotarget.15745] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
42 Kanda M, Tanaka H, Shimizu D, Miwa T, Umeda S, Tanaka C, Kobayashi D, Hattori N, Suenaga M, Hayashi M, Iwata N, Yamada S, Fujiwara M, Kodera Y. SYT7 acts as a driver of hepatic metastasis formation of gastric cancer cells. Oncogene. 2018;37:5355-5366. [PMID: 29858600 DOI: 10.1038/s41388-018-0335-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
43 Su X, Zhang J, Yang W, Liu Y, Liu Y, Shan Z, Wang W. Identification of the Prognosis-Related lncRNAs and Genes in Gastric Cancer. Front Genet 2020;11:27. [PMID: 32117443 DOI: 10.3389/fgene.2020.00027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
44 Kanda M, Tanaka C, Kobayashi D, Tanaka H, Shimizu D, Shibata M, Takami H, Hayashi M, Iwata N, Niwa Y, Yamada S, Fujii T, Nakayama G, Fujiwara M, Kodera Y. Epigenetic suppression of the immunoregulator MZB1 is associated with the malignant phenotype of gastric cancer. Int J Cancer 2016;139:2290-8. [PMID: 27459504 DOI: 10.1002/ijc.30286] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
45 Liu H, Li F, Zhu Y, Li T, Huang H, Lin T, Hu Y, Qi X, Yu J, Li G. Whole-exome sequencing to identify somatic mutations in peritoneal metastatic gastric adenocarcinoma: A preliminary study. Oncotarget 2016;7:43894-906. [PMID: 27270314 DOI: 10.18632/oncotarget.9707] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
46 Huang R, He L, Xia Y, Xu H, Liu C, Xie H, Wang S, Peng L, Liu Y, Liu Y, He N, Li Z. A Sensitive Aptasensor Based on a Hemin/G-Quadruplex-Assisted Signal Amplification Strategy for Electrochemical Detection of Gastric Cancer Exosomes. Small 2019;15:e1900735. [PMID: 30963720 DOI: 10.1002/smll.201900735] [Cited by in Crossref: 101] [Cited by in F6Publishing: 81] [Article Influence: 33.7] [Reference Citation Analysis]
47 Heitor da Silva Maués J, Ferreira Ribeiro H, de Maria Maués Sacramento R, Maia de Sousa R, Pereira de Tommaso R, Dourado Kovacs Machado Costa B, Cardoso Soares P, Pimentel Assumpção P, de Fátima Aquino Moreira-Nunes C, Mário Rodriguez Burbano R. Downregulated genes by silencing MYC pathway identified with RNA-SEQ analysis as potential prognostic biomarkers in gastric adenocarcinoma. Aging (Albany NY) 2020;12:24651-70. [PMID: 33351778 DOI: 10.18632/aging.202260] [Reference Citation Analysis]
48 Kanda M, Murotani K, Tanaka H, Miwa T, Umeda S, Tanaka C, Kobayashi D, Hayashi M, Hattori N, Suenaga M, Yamada S, Nakayama G, Fujiwara M, Kodera Y. Integrated multigene expression panel to prognosticate patients with gastric cancer. Oncotarget 2018;9:18775-85. [PMID: 29721160 DOI: 10.18632/oncotarget.24661] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
49 Che K, Liu F, Wu N, Liu Q, Yuan L, Wei J. Individualized prediction of survival benefits from perioperative chemoradiotherapy for patients with resectable gastric cancer. Cancer Med 2020;9:7137-50. [PMID: 32810384 DOI: 10.1002/cam4.3350] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Jiang Y, Zhang Q, Hu Y, Li T, Yu J, Zhao L, Ye G, Deng H, Mou T, Cai S, Zhou Z, Liu H, Chen G, Li G, Qi X. ImmunoScore Signature: A Prognostic and Predictive Tool in Gastric Cancer. Ann Surg. 2018;267:504-513. [PMID: 28002059 DOI: 10.1097/sla.0000000000002116] [Cited by in Crossref: 158] [Cited by in F6Publishing: 143] [Article Influence: 52.7] [Reference Citation Analysis]
51 Veitch AM, Uedo N, Yao K, East JE. Optimizing early upper gastrointestinal cancer detection at endoscopy. Nat Rev Gastroenterol Hepatol. 2015;12:660-667. [PMID: 26260369 DOI: 10.1038/nrgastro.2015.128] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 6.6] [Reference Citation Analysis]
52 Saavedra K, Valbuena J, Olivares W, Marchant MJ, Rodríguez A, Torres-estay V, Carrasco-avino G, Guzmán L, Aguayo F, Roa JC, Corvalán AH, Soutto M. Loss of Expression of Reprimo, a p53-induced Cell Cycle Arrest Gene, Correlates with Invasive Stage of Tumor Progression and p73 Expression in Gastric Cancer. PLoS ONE 2015;10:e0125834. [DOI: 10.1371/journal.pone.0125834] [78495111110.1371/journal.pone.0125834','', '1007-9327')">Reference Citation Analysis]
53 Binato R, Santos EC, Boroni M, Demachki S, Assumpção P, Abdelhay E. A common molecular signature of intestinal-type gastric carcinoma indicates processes related to gastric carcinogenesis. Oncotarget 2018;9:7359-71. [PMID: 29484116 DOI: 10.18632/oncotarget.23670] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
54 Necula LG, Mambet C, Albulescu R, Diaconu CC. Epigenetics in gastric carcinogenesis: TET genes as important players. J Immunoassay Immunochem 2015;36:445-55. [PMID: 25714048 DOI: 10.1080/15321819.2015.1017402] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
55 Li YR, Wen LQ, Wang Y, Zhou TC, Ma N, Hou ZH, Jiang ZP. MicroRNA-520c enhances cell proliferation, migration, and invasion by suppressing IRF2 in gastric cancer. FEBS Open Bio 2016;6:1257-66. [PMID: 28203525 DOI: 10.1002/2211-5463.12142] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
56 Roszczenko-Jasińska P, Wojtyś MI, Jagusztyn-Krynicka EK. Helicobacter pylori treatment in the post-antibiotics era-searching for new drug targets. Appl Microbiol Biotechnol 2020;104:9891-905. [PMID: 33052519 DOI: 10.1007/s00253-020-10945-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
57 Sun C, Tao Y, Gao Y, Xia Y, Liu Y, Wang G, Gu Y. F-box protein 11 promotes the growth and metastasis of gastric cancer via PI3K/AKT pathway-mediated EMT. Biomedicine & Pharmacotherapy 2018;98:416-23. [DOI: 10.1016/j.biopha.2017.12.088] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
58 Dong Y, Li X, Lin Z, Zou W, Liu Y, Qian H, Jia J. HOXC-AS1-MYC regulatory loop contributes to the growth and metastasis in gastric cancer. J Exp Clin Cancer Res 2019;38:502. [PMID: 31870402 DOI: 10.1186/s13046-019-1482-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
59 Yang Q, Zhu C, Zhang Y, Wang Y, Wang Y, Zhu L, Yang X, Li J, Nie H, Jiang S, Zhang X, Cao X, Li Q, Zhang X, Tian G, Hu L, Zhu L, Zhao G, Zhang Z. Molecular analysis of gastric cancer identifies genomic markers of drug sensitivity in Asian gastric cancer. J Cancer 2018;9:2973-80. [PMID: 30123366 DOI: 10.7150/jca.25506] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
60 Mocellin S, Verdi D, Pooley KA, Nitti D. Genetic variation and gastric cancer risk: a field synopsis and meta-analysis. Gut. 2015;64:1209-1219. [PMID: 25731870 DOI: 10.1136/gutjnl-2015-309168] [Cited by in Crossref: 106] [Cited by in F6Publishing: 113] [Article Influence: 15.1] [Reference Citation Analysis]
61 Kim HY, Cho Y, Kang H, Yim YS, Kim SJ, Song J, Chun KH. Targeting the WEE1 kinase as a molecular targeted therapy for gastric cancer. Oncotarget 2016;7:49902-16. [PMID: 27363019 DOI: 10.18632/oncotarget.10231] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
62 Li H, Wu Y, Zhao R, Chen X, Ren W, Li H, Han P, Shao Y, Wang J. IL-1RN gene polymorphisms reduces thyroid cancer risk in Chinese Han population. Mol Carcinog 2020;59:1140-6. [PMID: 32790111 DOI: 10.1002/mc.23244] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
63 Du J, Liang Y, Li J, Zhao JM, Wang ZN, Lin XY. Gastric Cancer Cell-Derived Exosomal microRNA-23a Promotes Angiogenesis by Targeting PTEN. Front Oncol 2020;10:326. [PMID: 32232005 DOI: 10.3389/fonc.2020.00326] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
64 Fonseca Cabral G, Azevedo Dos Santos Pinheiro J, Vidal AF, Santos S, Ribeiro-Dos-Santos Â. piRNAs in Gastric Cancer: A New Approach Towards Translational Research. Int J Mol Sci 2020;21:E2126. [PMID: 32204558 DOI: 10.3390/ijms21062126] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
65 Kanda M, Shimizu D, Fujii T, Sueoka S, Tanaka Y, Ezaka K, Takami H, Tanaka H, Hashimoto R, Iwata N. Function and diagnostic value of Anosmin-1 in gastric cancer progression. Int J Cancer. 2016;138:721-730. [PMID: 26270236 DOI: 10.1002/ijc.29803] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 6.1] [Reference Citation Analysis]
66 Zeng C, Yan R, Yang G, Xiang S, Zhao F. Hedgehog signaling activation required for glypican-6-mediated regulation of invasion, migration, and epithelial-mesenchymal transition of gastric cancer cells. Biosci Rep 2020;40:BSR20193181. [PMID: 32478377 DOI: 10.1042/BSR20193181] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Carvajal-Carmona LG. PALB2 as a familial gastric cancer gene: is the wait over? Lancet Gastroenterol Hepatol 2018;3:451-2. [PMID: 29706559 DOI: 10.1016/S2468-1253(18)30120-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
68 Skierucha M, Milne AN, Offerhaus GJA, Polkowski WP, Maciejewski R, Sitarz R. Molecular alterations in gastric cancer with special reference to the early-onset subtype. World J Gastroenterol 2016; 22(8): 2460-2474 [PMID: 26937134 DOI: 10.3748/wjg.v22.i8.2460] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
69 Al-Hamamah MA, Alotaibi MR, Ahmad SF, Ansari MA, Attia MSM, Nadeem A, Bakheet SA, As Sobeai HM, Attia SM. Genetic and epigenetic alterations induced by the small-molecule panobinostat: A mechanistic study at the chromosome and gene levels. DNA Repair (Amst) 2019;78:70-80. [PMID: 30978576 DOI: 10.1016/j.dnarep.2019.03.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
70 Oliveira GRC, Anna CCS, Lamarão LM, Guimarães AC, da Rocha CM, Bahia MO, de Souza CR, Calcagno DQ, de Assumpção PP, Burbano RR. Quantitative difference of oral pathogen between individuals with gastric cancer and individuals without cancer. Oncotarget 2021;12:1677-86. [PMID: 34434496 DOI: 10.18632/oncotarget.28034] [Reference Citation Analysis]
71 Kanda M, Murotani K, Tanaka H, Miwa T, Umeda S, Tanaka C, Kobayashi D, Hayashi M, Hattori N, Suenaga M, Yamada S, Nakayama G, Fujiwara M, Kodera Y. A novel dual-marker expression panel for easy and accurate risk stratification of patients with gastric cancer. Cancer Med 2018;7:2463-71. [PMID: 29733517 DOI: 10.1002/cam4.1522] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
72 El-assaad F, Gong L, Gia A, Yim HCH, El-omar EM. Helicobacter pylori, Peptic Ulcer Disease and Gastric Cancer. Gastrointestinal Diseases and their Associated Infections. Elsevier; 2019. pp. 17-29. [DOI: 10.1016/b978-0-323-54843-4.00002-7] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
73 Ahadi A. Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression. IUBMB Life 2020;72:884-98. [DOI: 10.1002/iub.2259] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
74 Jiang ZH, Peng T, Qian HL, Lu CD, Qiu F, Zhang SZ. DNA damage-induced activation of ATM promotes β-TRCP-mediated ARID1A ubiquitination and destruction in gastric cancer cells. Cancer Cell Int 2019;19:162. [PMID: 31210753 DOI: 10.1186/s12935-019-0878-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
75 Li LQ, Yang Y, Chen H, Zhang L, Pan D, Xie WJ. MicroRNA-181b inhibits glycolysis in gastric cancer cells via targeting hexokinase 2 gene. Cancer Biomark 2016;17:75-81. [PMID: 27314295 DOI: 10.3233/CBM-160619] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 5.4] [Reference Citation Analysis]
76 Farhangian P, Jahandoost S, Mowla SJ, Khalili M. Differential expression of long non-coding RNA SOX2OT in gastric adenocarcinoma. Cancer Biomark 2018;23:221-5. [PMID: 30198866 DOI: 10.3233/CBM-181325] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
77 Liu HT, Liu S, Liu L, Ma RR, Gao P. EGR1-Mediated Transcription of lncRNA-HNF1A-AS1 Promotes Cell-Cycle Progression in Gastric Cancer. Cancer Res 2018;78:5877-90. [PMID: 30185552 DOI: 10.1158/0008-5472.CAN-18-1011] [Cited by in Crossref: 29] [Cited by in F6Publishing: 59] [Article Influence: 7.3] [Reference Citation Analysis]
78 Kim HS, Kim JW, Hwang IG, Lee HS, Kim WH. Expression of DNA Damage Response Markers in Early-Onset or Familial Gastric Cancers. Asian Pac J Cancer Prev 2019;20:1369-76. [PMID: 31127894 DOI: 10.31557/APJCP.2019.20.5.1369] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
79 Ren W, Li W, Wang D, Hu S, Suo J, Ying X. Combining multi-dimensional data to identify key genes and pathways in gastric cancer. PeerJ 2017;5:e3385. [PMID: 28603669 DOI: 10.7717/peerj.3385] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
80 Zhang JX, He WL, Feng ZH, Chen DL, Gao Y, He Y, Qin K, Zheng ZS, Chen C, Weng HW, Yun M, Ye S, Xu RH, Xie D. A positive feedback loop consisting of C12orf59/NF-κB/CDH11 promotes gastric cancer invasion and metastasis. J Exp Clin Cancer Res 2019;38:164. [PMID: 30987656 DOI: 10.1186/s13046-019-1114-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
81 Tang S, Lin L, Cheng J, Zhao J, Xuan Q, Shao J, Zhou Y, Zhang Y. The prognostic value of preoperative fibrinogen-to-prealbumin ratio and a novel FFC score in patients with resectable gastric cancer. BMC Cancer 2020;20:382. [PMID: 32375697 DOI: 10.1186/s12885-020-06866-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
82 Chen WM, Huang MD, Sun DP, Kong R, Xu TP, Xia R, Zhang EB, Shu YQ. Long intergenic non-coding RNA 00152 promotes tumor cell cycle progression by binding to EZH2 and repressing p15 and p21 in gastric cancer. Oncotarget. 2016;7:9773-9787. [PMID: 26799422 DOI: 10.18632/oncotarget.6949] [Cited by in Crossref: 87] [Cited by in F6Publishing: 91] [Article Influence: 14.5] [Reference Citation Analysis]
83 Hung YH, Hsu MC, Chen LT, Hung WC, Pan MR. Alteration of Epigenetic Modifiers in Pancreatic Cancer and Its Clinical Implication. J Clin Med 2019;8:E903. [PMID: 31238554 DOI: 10.3390/jcm8060903] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
84 Deng W, Zhang Y, Cai J, Zhang J, Liu X, Yin J, Bai Z, Yao H, Zhang Z. LncRNA-ANRIL promotes gastric cancer progression by enhancing NF-kB signaling. Exp Biol Med (Maywood) 2019;244:953-9. [PMID: 31242038 DOI: 10.1177/1535370219860207] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
85 Choi YJ, Ohn JH, Kim N, Kim W, Park K, Won S, Sael L, Shin CM, Lee SM, Lee S, An HJ, Jang DM, Han BW, Lee HS, Kang SJ, Kim JS, Lee DH. Family-based exome sequencing combined with linkage analyses identifies rare susceptibility variants of MUC4 for gastric cancer. PLoS One 2020;15:e0236197. [PMID: 32701958 DOI: 10.1371/journal.pone.0236197] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
86 Wang Z, Dai J, Hu N, Miao X, Abnet CC, Yang M, Freedman ND, Chen J, Burdette L, Zhu X, Chung CC, Ren C, Dawsey SM, Wang M, Ding T, Du J, Gao YT, Zhong R, Giffen C, Pan W, Koh WP, Dai N, Liao LM, Yan C, Qiao YL, Jiang Y, Shu XO, Chen J, Wang C, Ma H, Su H, Zhang Z, Wang L, Wu C, Xiang YB, Hu Z, Yuan JM, Xie L, Zheng W, Lin D, Chanock SJ, Shi Y, Goldstein AM, Jin G, Taylor PR, Shen H. Identification of new susceptibility loci for gastric non-cardia adenocarcinoma: pooled results from two Chinese genome-wide association studies. Gut 2017;66:581-7. [PMID: 26701879 DOI: 10.1136/gutjnl-2015-310612] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 5.7] [Reference Citation Analysis]
87 Lin JX, Lin JP, Weng Y, Lv CB, Chen JH, Zhan CY, Li P, Xie JW, Wang JB, Lu J, Chen QY, Cao LL, Lin M, Zhou WX, Zhang XJ, Zheng CH, Cai LS, Ma YB, Huang CM. Radiographical Evaluation of Tumor Immunosuppressive Microenvironment and Treatment Outcomes in Gastric Cancer: A Retrospective, Multicohort Study. Ann Surg Oncol 2022. [PMID: 35294651 DOI: 10.1245/s10434-022-11499-z] [Reference Citation Analysis]
88 Ahn HJ, Lee DS. Helicobacter pylori in gastric carcinogenesis. World J Gastrointest Oncol 2015; 7(12): 455-465 [PMID: 26690981 DOI: 10.4251/wjgo.v7.i12.455] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
89 Balmeh N, Mahmoudi S, Karabedianhajiabadi A. piRNAs and PIWI proteins: From biogenesis to their role in cancer. Gene Reports 2021;22:101013. [DOI: 10.1016/j.genrep.2020.101013] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
90 Bao G, Qu F, He L, Zhao H, Wang N, Ji G, He X. Prognostic Significance of Tag SNP rs1045411 in HMGB1 of the Aggressive Gastric Cancer in a Chinese Population. PLoS One 2016;11:e0154378. [PMID: 27116470 DOI: 10.1371/journal.pone.0154378] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
91 Nilsaz-Dezfouli H, Abu-Bakar MR, Arasan J, Adam MB, Pourhoseingholi MA. Improving Gastric Cancer Outcome Prediction Using Single Time-Point Artificial Neural Network Models. Cancer Inform 2017;16:1176935116686062. [PMID: 28469384 DOI: 10.1177/1176935116686062] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
92 Castro F, Shahal D, Tarajia M, Velásquez IM, Causadias MT, Herrera V, Gómez B, Cukier M, Motta J. Baseline characteristics, survival and direct costs associated to treatment of gastric cancer patients at the National Oncology Institute of Panama from 2012 to 2015: a hospital-based observational study. BMJ Open 2017;7:e017266. [PMID: 28947456 DOI: 10.1136/bmjopen-2017-017266] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
93 Abdi E, Latifi-Navid S, Zahri S, Yazdanbod A, Pourfarzi F. Risk factors predisposing to cardia gastric adenocarcinoma: Insights and new perspectives. Cancer Med 2019;8:6114-26. [PMID: 31448582 DOI: 10.1002/cam4.2497] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 10.0] [Reference Citation Analysis]
94 Zhan XY, Zhang Y, Zhai E, Zhu QY, He Y. Sorting nexin-1 is a candidate tumor suppressor and potential prognostic marker in gastric cancer. PeerJ 2018;6:e4829. [PMID: 29868263 DOI: 10.7717/peerj.4829] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
95 Luo C, Sun F, Zhu H, Ni Y, Fang J, Liu Y, Shao S, Shen H, Hu J. Insulin-like growth factor binding protein-1 (IGFBP-1) upregulated by Helicobacter pylori and is associated with gastric cancer cells migration. Pathol Res Pract 2017;213:1029-36. [PMID: 28864349 DOI: 10.1016/j.prp.2017.08.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
96 Juarez I, Gutierrez A, Vaquero-Yuste C, Molanes-López EM, López A, Lasa I, Gómez R, Martin-Villa JM. TGFB1 polymorphisms and TGF-β1 plasma levels identify gastric adenocarcinoma patients with lower survival rate and disseminated disease. J Cell Mol Med 2021;25:774-83. [PMID: 33274798 DOI: 10.1111/jcmm.16131] [Reference Citation Analysis]
97 Han W, Zhang Z, He B, Xu Y, Zhang J, Cao W. Integrated analysis of long non-coding RNAs in human gastric cancer: An in silico study. PLoS One 2017;12:e0183517. [PMID: 28841672 DOI: 10.1371/journal.pone.0183517] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
98 Maatough A, Whitfield GK, Brook L, Hsieh D, Palade P, Hsieh JC. Human Hairless Protein Roles in Skin/Hair and Emerging Connections to Brain and Other Cancers. J Cell Biochem 2018;119:69-80. [PMID: 28543886 DOI: 10.1002/jcb.26164] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
99 Hugen S, Thomas RE, German AJ, Burgener IA, Mandigers PJJ. Gastric carcinoma in canines and humans, a review. Vet Comp Oncol 2017;15:692-705. [PMID: 27549077 DOI: 10.1111/vco.12249] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
100 Li T, Zhang Q, Jiang Y, Yu J, Hu Y, Mou T, Chen G, Li G. Gastric cancer cells inhibit natural killer cell proliferation and induce apoptosis via prostaglandin E2. Oncoimmunology 2016;5:e1069936. [PMID: 27057432 DOI: 10.1080/2162402X.2015.1069936] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 3.9] [Reference Citation Analysis]
101 Yan C, Zhu M, Ding Y, Yang M, Wang M, Li G, Ren C, Huang T, Yang W, He B, Wang M, Yu F, Wang J, Zhang R, Wang T, Ni J, Chen J, Jiang Y, Dai J, Zhang E, Ma H, Wang Y, Xu D, Wang S, Chen Y, Xu Z, Zhou J, Ji G, Wang Z, Zhang Z, Hu Z, Wei Q, Shen H, Jin G. Meta-analysis of genome-wide association studies and functional assays decipher susceptibility genes for gastric cancer in Chinese populations. Gut 2020;69:641-51. [DOI: 10.1136/gutjnl-2019-318760] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
102 Hosseinzadeh A, Ardebili SM. Efficacy of Omega Fatty Acid Supplementation on mRNA Expression Level of Tumor Necrosis Factor Alpha in Patients with Gastric Adenocarcinoma. J Gastrointest Cancer 2016;47:287-93. [PMID: 27170003 DOI: 10.1007/s12029-016-9826-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
103 Cover TL. Helicobacter pylori diversity and gastric cancer risk. MBio. 2016;7:e01869-e01815. [PMID: 26814181 DOI: 10.1128/mbio.01869-15] [Cited by in Crossref: 99] [Cited by in F6Publishing: 65] [Article Influence: 16.5] [Reference Citation Analysis]
104 Wu SJ, Jiang SY, Wu J, Xiong GL. Association between EGF +61 A>G polymorphism and gastric cancer risk: A meta-analysis. J Huazhong Univ Sci Technolog Med Sci 2015;35:327-32. [PMID: 26072068 DOI: 10.1007/s11596-015-1432-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
105 Yan H, Qiu C, Sun W, Gu M, Xiao F, Zou J, Zhang L. Yap regulates gastric cancer survival and migration via SIRT1/Mfn2/mitophagy. Oncol Rep 2018;39:1671-81. [PMID: 29436693 DOI: 10.3892/or.2018.6252] [Cited by in Crossref: 11] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
106 Khouzam RA, Molinari C, Salvi S, Marabelli M, Molinaro V, Orioli D, Saragoni L, Morgagni P, Calistri D, Ranzani GN. Digital PCR identifies changes in CDH1 (E-cadherin) transcription pattern in intestinal-type gastric cancer. Oncotarget. 2017;8:18811-18820. [PMID: 27861150 DOI: 10.18632/oncotarget.13401] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
107 Perrin D, Zuccon G. Recursive module extraction using Louvain and PageRank. F1000Res 2018;7:1286. [PMID: 30271588 DOI: 10.12688/f1000research.15845.1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
108 Magalhães L, Quintana LG, Lopes DCF, Vidal AF, Pereira AL, D'Araujo Pinto LC, de Jesus Viana Pinheiro J, Khayat AS, Goulart LR, Burbano R, de Assumpção PP, Ribeiro-Dos-Santos Â. APC gene is modulated by hsa-miR-135b-5p in both diffuse and intestinal gastric cancer subtypes. BMC Cancer 2018;18:1055. [PMID: 30376837 DOI: 10.1186/s12885-018-4980-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
109 Sánchez-Zauco N, Torres J, Gómez A, Camorlinga-Ponce M, Muñoz-Pérez L, Herrera-Goepfert R, Medrano-Guzmán R, Giono-Cerezo S, Maldonado-Bernal C. Circulating blood levels of IL-6, IFN-γ, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study. BMC Cancer 2017;17:384. [PMID: 28558708 DOI: 10.1186/s12885-017-3310-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
110 Zhang B, Wu J, Cai Y, Luo M, Wang B, Gu Y. TCF7L1 indicates prognosis and promotes proliferation through activation of Keap1/NRF2 in gastric cancer. Acta Biochim Biophys Sin (Shanghai) 2019;51:375-85. [PMID: 30811526 DOI: 10.1093/abbs/gmz015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
111 Wang Q, Liu Q, Wang T, Yang H, Han Z, Zhang P. Endothelial cell protein C receptor promotes MGC803 gastric cancer cells proliferation and migration by activating ERK1/2. Med Oncol 2015;32:162. [PMID: 25895599 DOI: 10.1007/s12032-015-0614-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
112 Korourian A, Roudi R, Shariftabrizi A, Kalantari E, Sotoodeh K, Madjd Z. Differential role of Wnt signaling and base excision repair pathways in gastric adenocarcinoma aggressiveness. Clin Exp Med 2017;17:505-17. [PMID: 27909884 DOI: 10.1007/s10238-016-0443-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
113 Kanda M, Kodera Y. Recent advances in the molecular diagnostics of gastric cancer. World J Gastroenterol 2015; 21(34): 9838-9852 [PMID: 26379391 DOI: 10.3748/wjg.v21.i34.9838] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 64] [Article Influence: 9.3] [Reference Citation Analysis]
114 Kanda M, Shimizu D, Tanaka H, Shibata M, Iwata N, Hayashi M, Kobayashi D, Tanaka C, Yamada S, Fujii T. Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer. Oncotarget. 2016;7:13667-13679. [PMID: 26872374 DOI: 10.18632/oncotarget.7269] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 7.4] [Reference Citation Analysis]
115 Paul P, Malakar AK, Chakraborty S. The significance of gene mutations across eight major cancer types. Mutat Res Rev Mutat Res 2019;781:88-99. [PMID: 31416581 DOI: 10.1016/j.mrrev.2019.04.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
116 Wang X, Wu C, Yuan B, Wang D, Liu H, Feng H, Sun S. Low scavenger receptor class B type I expression is associated with gastric adenocarcinoma tumor aggressiveness. Oncol Lett 2018;15:4604-10. [PMID: 29541232 DOI: 10.3892/ol.2018.7889] [Reference Citation Analysis]
117 Ieni A, Barresi V, Rigoli L, Caruso RA, Tuccari G. HER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the Stomach. Dis Markers 2015;2015:234851. [PMID: 26494937 DOI: 10.1155/2015/234851] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
118 Saavedra K, Valbuena J, Olivares W, Marchant MJ, Rodríguez A, Torres-Estay V, Carrasco-Avino G, Guzmán L, Aguayo F, Roa JC. Loss of Expression of Reprimo, a p53-induced Cell Cycle Arrest Gene, Correlates with Invasive Stage of Tumor Progression and p73 Expression in Gastric Cancer. PLoS One. 2015;10:e0125834. [PMID: 25954972 DOI: 10.1371/journal.pone.0125834] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
119 Park H, Cho SY, Kim H, Na D, Han JY, Chae J, Park C, Park OK, Min S, Kang J, Choi B, Min J, Kwon JY, Suh YS, Kong SH, Lee HJ, Liu ET, Kim JI, Kim S, Yang HK, Lee C. Genomic alterations in BCL2L1 and DLC1 contribute to drug sensitivity in gastric cancer. Proc Natl Acad Sci U S A 2015;112:12492-7. [PMID: 26401016 DOI: 10.1073/pnas.1507491112] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
120 Braga LLBC, Ramos AN, Braga Neto MB, Ferreira AF, Queiroz DMM, Maia DCC, Alencar CH, Heukelbach J. Unequal burden of mortality from gastric cancer in Brazil and its regions, 2000–2015. Gastric Cancer 2019;22:675-83. [DOI: 10.1007/s10120-018-00916-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
121 Nakayama I, Shinozaki E, Sakata S, Yamamoto N, Fujisaki J, Muramatsu Y, Hirota T, Takeuchi K, Takahashi S, Yamaguchi K, Noda T. Enrichment of CLDN18-ARHGAP fusion gene in gastric cancers in young adults. Cancer Sci 2019;110:1352-63. [PMID: 30771244 DOI: 10.1111/cas.13967] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
122 Chen W, Xiao J, Shi L, Lin L, Jiang M, Ge Y, Li Z, Fan H, Yang L, Xu Z. Association of TP73-AS1 gene polymorphisms with the risk and survival of gastric cancer in a Chinese Han Population. Artif Cells Nanomed Biotechnol. 2019;47:3814-3822. [PMID: 31549851 DOI: 10.1080/21691401.2019.1669621] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
123 Tao Y, Song Y, Han T, Wang C, Zhao T, Gu Y. miR-205 regulation of ICT1 has an oncogenic potential via promoting the migration and invasion of gastric cancer cells. Biomed Pharmacother 2017;96:191-7. [PMID: 28987942 DOI: 10.1016/j.biopha.2017.09.147] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
124 Jiang Y, Liu W, Li T, Hu Y, Chen S, Xi S, Wen Y, Huang L, Zhao L, Xiao C, Huang X, Han Z, Liu H, Qi X, Yang Y, Yu J, Cai S, Li G. Prognostic and Predictive Value of p21-activated Kinase 6 Associated Support Vector Machine Classifier in Gastric Cancer Treated by 5-fluorouracil/Oxaliplatin Chemotherapy. EBioMedicine 2017;22:78-88. [PMID: 28687498 DOI: 10.1016/j.ebiom.2017.06.028] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
125 Wang X, Zhang Y, Jiang L, Zhou F, Zhai H, Zhang M, Wang J. Interpreting the distinct and shared genetic characteristics between Epstein-Barr virus associated and non-associated gastric carcinoma. Gene. 2016;576:798-806. [PMID: 26584536 DOI: 10.1016/j.gene.2015.11.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
126 Yan C, Song X, Wang S, Wang J, Li L. Knockdown of PDIA6 Inhibits Cell Proliferation and Enhances the Chemosensitivity in Gastric Cancer Cells. Cancer Manag Res 2020;12:11051-62. [PMID: 33173338 DOI: 10.2147/CMAR.S267711] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
127 Uno Y, Kanda M, Miwa T, Umeda S, Tanaka H, Tanaka C, Kobayashi D, Suenaga M, Hattori N, Hayashi M, Yamada S, Nakayama G, Fujiwara M, Kodera Y. Increased Expression of DNAJC12 is Associated with Aggressive Phenotype of Gastric Cancer. Ann Surg Oncol 2019;26:836-44. [PMID: 30617870 DOI: 10.1245/s10434-018-07149-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
128 Ruggieri V, Russi S, Zoppoli P, La Rocca F, Angrisano T, Falco G, Calice G, Laurino S. The Role of MicroRNAs in the Regulation of Gastric Cancer Stem Cells: A Meta-Analysis of the Current Status. J Clin Med 2019;8:E639. [PMID: 31075910 DOI: 10.3390/jcm8050639] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
129 Yu B, Gu D, Zhang X, Li J, Liu B, Xie J. GLI1-mediated regulation of side population is responsible for drug resistance in gastric cancer. Oncotarget 2017;8:27412-27. [PMID: 28404967 DOI: 10.18632/oncotarget.16174] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
130 Xiao H, Zhang Y, Kim Y, Kim S, Kim JJ, Kim KM, Yoshizawa J, Fan LY, Cao CX, Wong DT. Differential Proteomic Analysis of Human Saliva using Tandem Mass Tags Quantification for Gastric Cancer Detection. Sci Rep 2016;6:22165. [PMID: 26911362 DOI: 10.1038/srep22165] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 9.2] [Reference Citation Analysis]
131 Karpińska-Kaczmarczyk K, Lewandowska M, Ławniczak M, Białek A, Urasińska E. Expression of Mismatch Repair Proteins in Early and Advanced Gastric Cancer in Poland. Med Sci Monit 2016;22:2886-92. [PMID: 27527654 DOI: 10.12659/msm.897150] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
132 Lage J, Uedo N, Dinis-Ribeiro M, Yao K. Surveillance of patients with gastric precancerous conditions. Best Pract Res Clin Gastroenterol. 2016;30:913-922. [PMID: 27938786 DOI: 10.1016/j.bpg.2016.09.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
133 Liou JM, Lee YC, El-Omar EM, Wu MS. Efficacy and Long-Term Safety of H. pylori Eradication for Gastric Cancer Prevention. Cancers (Basel) 2019;11:E593. [PMID: 31035365 DOI: 10.3390/cancers11050593] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
134 Du S, Miao J, Zhu Z, Xu E, Shi L, Ai S, Wang F, Kang X, Chen H, Lu X, Guan W, Xia X. NADPH oxidase 4 regulates anoikis resistance of gastric cancer cells through the generation of reactive oxygen species and the induction of EGFR. Cell Death Dis 2018;9:948. [PMID: 30237423 DOI: 10.1038/s41419-018-0953-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
135 Vinasco-Sandoval T, Moreira FC, F Vidal A, Pinto P, Ribeiro-Dos-Santos AM, Cruz RLS, Fonseca Cabral G, Anaissi AKM, Lopes KP, Ribeiro-Dos-Santos A, Demachki S, de Assumpção PP, Ribeiro-Dos-Santos Â, Santos S. Global Analyses of Expressed Piwi-Interacting RNAs in Gastric Cancer. Int J Mol Sci 2020;21:E7656. [PMID: 33081152 DOI: 10.3390/ijms21207656] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
136 Zhu J, Wang X, Guan H, Xiao Q, Wu Z, Shi J, Zhang F, Gao P, Song Y, Wang Z. HIP1R acts as a tumor suppressor in gastric cancer by promoting cancer cell apoptosis and inhibiting migration and invasion through modulating Akt. J Clin Lab Anal 2020;34:e23425. [PMID: 32548851 DOI: 10.1002/jcla.23425] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
137 Wang S, Liu F, Deng J, Cai X, Han J, Liu Q. Long Noncoding RNA ROR Regulates Proliferation, Invasion, and Stemness of Gastric Cancer Stem Cell. Cell Reprogram 2016;18:319-26. [PMID: 27602437 DOI: 10.1089/cell.2016.0001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
138 Gao S, Zhao ZY, Wu R, Zhang Y, Zhang ZY. Prognostic value of long noncoding RNAs in gastric cancer: a meta-analysis. Onco Targets Ther 2018;11:4877-91. [PMID: 30147339 DOI: 10.2147/OTT.S169823] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
139 Jiang Y, Yuan Q, Lv W, Xi S, Huang W, Sun Z, Chen H, Zhao L, Liu W, Hu Y, Lu L, Ma J, Li T, Yu J, Wang Q, Li G. Radiomic signature of 18F fluorodeoxyglucose PET/CT for prediction of gastric cancer survival and chemotherapeutic benefits. Theranostics. 2018;8:5915-5928. [PMID: 30613271 DOI: 10.7150/thno.28018] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 10.3] [Reference Citation Analysis]
140 Dehdashtian E, Tabatabaeian H, Ghaedi K, Talebi A, Adami B. A H. pylori-independent miR-21 overexpression in gastric cancer patients. Gene Reports 2019;17:100528. [DOI: 10.1016/j.genrep.2019.100528] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
141 Alzeeb G, Metges JP, Corcos L, Le Jossic-Corcos C. Three-Dimensional Culture Systems in Gastric Cancer Research. Cancers (Basel) 2020;12:E2800. [PMID: 33003476 DOI: 10.3390/cancers12102800] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
142 Sawaki K, Kanda M, Miwa T, Umeda S, Tanaka H, Tanaka C, Kobayashi D, Suenaga M, Hattori N, Hayashi M, Yamada S, Nakayama G, Fujiwara M, Kodera Y. Troponin I2 as a Specific Biomarker for Prediction of Peritoneal Metastasis in Gastric Cancer. Ann Surg Oncol 2018;25:2083-90. [PMID: 29663169 DOI: 10.1245/s10434-018-6480-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
143 Özcan Ö, Belli AK, Sakallı Çetin E, Kara M, Çelik Öİ, Kaplan M, Kayılıoğlu SI, Dönmez C, Polat M. Upregulation of SIRT1 gene in gastric adenocarcinoma. Turk J Gastroenterol 2019;30:326-30. [PMID: 30945643 DOI: 10.5152/tjg.2019.18550] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
144 Shan MJ, Meng LB, Guo P, Zhang YM, Kong D, Liu YB. Screening and Identification of Key Biomarkers of Gastric Cancer: Three Genes Jointly Predict Gastric Cancer. Front Oncol 2021;11:591893. [PMID: 34485109 DOI: 10.3389/fonc.2021.591893] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
145 de Mello RA, Amaral GA, Neves NM, Lippo EG, Parini F, Xu S, Tolia M, Charalampakis N, Tadokoro H, Castelo-Branco P, Zhu J. Current and potential biomarkers in gastric cancer: a critical review of the literature. Future Oncol 2021;17:3383-96. [PMID: 34291647 DOI: 10.2217/fon-2021-0084] [Reference Citation Analysis]
146 Kobayashi T, Ishida J, Shimizu Y, Kawakami H, Suda G, Muranaka T, Komatsu Y, Asaka M, Sakamoto N. Decreased RNA-binding motif 5 expression is associated with tumor progression in gastric cancer. Tumour Biol 2017;39:1010428317694547. [PMID: 28347247 DOI: 10.1177/1010428317694547] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
147 Cheng S, Ray D, Lee RTH, Naripogu KB, Yusoff PABM, Goh PBL, Liu Y, Suzuki Y, Das K, Chan HS, Wong WK, Chan WH, Chow PK, Ong HS, Raj P, Soo KC, Tan P, Epstein DM, Rozen SG. A functional network of gastric-cancer-associated splicing events controlled by dysregulated splicing factors. NAR Genom Bioinform 2020;2:lqaa013. [PMID: 33575575 DOI: 10.1093/nargab/lqaa013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
148 Kim Y, Cho MY, Kim J, Kim SN, Oh SC, Lee KA. Profiling cancer-associated genetic alterations and molecular classification of cancer in Korean gastric cancer patients. Oncotarget 2017;8:69888-905. [PMID: 29050249 DOI: 10.18632/oncotarget.19435] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
149 Kuo WY, Lin JJ, Hsu HJ, Chen HS, Yang AS, Wu CY. Noninvasive assessment of characteristics of novel anti-HER2 antibodies by molecular imaging in a human gastric cancer xenograft-bearing mouse model. Sci Rep 2018;8:13735. [PMID: 30214017 DOI: 10.1038/s41598-018-32094-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
150 Liu X, Meltzer SJ. Gastric Cancer in the Era of Precision Medicine. Cell Mol Gastroenterol Hepatol 2017;3:348-58. [PMID: 28462377 DOI: 10.1016/j.jcmgh.2017.02.003] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 11.4] [Reference Citation Analysis]
151 Chan TH, Qamra A, Tan KT, Guo J, Yang H, Qi L, Lin JS, Ng VH, Song Y, Hong H. ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer. Gastroenterology. 2016;151:637-650.e10. [PMID: 27373511 DOI: 10.1053/j.gastro.2016.06.043] [Cited by in Crossref: 72] [Cited by in F6Publishing: 70] [Article Influence: 12.0] [Reference Citation Analysis]
152 Rudnicka K, Backert S, Chmiela M. Genetic Polymorphisms in Inflammatory and Other Regulators in Gastric Cancer: Risks and Clinical Consequences. Curr Top Microbiol Immunol. 2019;421:53-76. [PMID: 31123885 DOI: 10.1007/978-3-030-15138-6_3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
153 Li F, Shi J, Xu Z, Yao X, Mou T, Yu J, Liu H, Li G. S100A4-MYH9 Axis Promote Migration and Invasion of Gastric Cancer Cells by Inducing TGF-β-Mediated Epithelial-Mesenchymal Transition. J Cancer 2018;9:3839-49. [PMID: 30410586 DOI: 10.7150/jca.25469] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
154 Yan Y, Wang R, Guan W, Qiao M, Wang L. Roles of microRNAs in cancer associated fibroblasts of gastric cancer. Pathol Res Pract 2017;213:730-6. [PMID: 28554761 DOI: 10.1016/j.prp.2017.02.020] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
155 Pecqueux M, Fritzmann J, Adamu M, Thorlund K, Kahlert C, Reißfelder C, Weitz J, Rahbari NN. Free intraperitoneal tumor cells and outcome in gastric cancer patients: a systematic review and meta-analysis. Oncotarget 2015;6:35564-78. [PMID: 26384352 DOI: 10.18632/oncotarget.5595] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
156 Liu P, Gao ZH, Ma JC, Yang J, Zhang YB, Yan HL, Yao JB, Da MX. Association between MUC1 rs4072037 polymorphism and susceptibility to gastric cancer: A meta-analysis based on ten case-control trials. Shijie Huaren Xiaohua Zazhi 2016; 24(34): 4576-4583 [DOI: 10.11569/wcjd.v24.i34.4576] [Reference Citation Analysis]
157 Neuper T, Frauenlob T, Posselt G, Horejs-hoeck J. Beyond the gastric epithelium — the paradox of Helicobacter pylori-induced immune responses. Current Opinion in Immunology 2022;76:102208. [DOI: 10.1016/j.coi.2022.102208] [Reference Citation Analysis]
158 Moss SF. The Clinical Evidence Linking Helicobacter pylori to Gastric Cancer. Cell Mol Gastroenterol Hepatol 2017;3:183-91. [PMID: 28275685 DOI: 10.1016/j.jcmgh.2016.12.001] [Cited by in Crossref: 102] [Cited by in F6Publishing: 90] [Article Influence: 17.0] [Reference Citation Analysis]
159 Namazi A, Forat-Yazdi M, Jafari M, Farahnak S, Nasiri R, Foroughi E, Abolbaghaei SM, Neamatzadeh H. Association of interleukin-10-1082 A/G (RS1800896) polymorphism with susceptibility to gastric cancer: Meta-analysis of 6,101 cases and 8,557 controls. Arq Gastroenterol. 2018;55:33-40. [PMID: 29561974 DOI: 10.1590/s0004-2803.201800000-18] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
160 Moghimi M, Dastgheib SA, Heiranizadeh N, Zare M, Sheikhpour E, Neamatzadeh H. ASSOCIATION OF IL-8 -251T>A (RS4073) POLYMORPHISM WITH SUSCEPTIBILITY TO GASTRIC CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS BASED ON 33 CASE-CONTROL STUDIES. Arq Gastroenterol. 2020;57:91-99. [PMID: 32294742 DOI: 10.1590/s0004-2803.202000000-16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
161 Loh JT, Beckett AC, Scholz MB, Cover TL. High-Salt Conditions Alter Transcription of Helicobacter pylori Genes Encoding Outer Membrane Proteins. Infect Immun. 2018;86:pii: e00626-17. [PMID: 29229727 DOI: 10.1128/iai.00626-17] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
162 Xiong W, Wang W, Huang H, Jiang Y, Guo W, Liu H, Yu J, Hu Y, Wan J, Li G. Prognostic Significance of PSMD1 Expression in Patients with Gastric Cancer. J Cancer 2019;10:4357-67. [PMID: 31413756 DOI: 10.7150/jca.31543] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
163 Zare A, Ganji M, Omrani MD, Alipoor B, Ghaedi H. Gastric Cancer MicroRNAs Meta-signature. Int J Mol Cell Med 2019;8:94-102. [PMID: 32215261 DOI: 10.22088/IJMCM.BUMS.8.2.94] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
164 Chen W, Huang C, Cheng W, Hung C, Huang M, Tai C, Liu Y, Chen C, Chang Y. Alpha 7-nicotinic acetylcholine receptor mediates the sensitivity of gastric cancer cells to 5-fluorouracil. Tumor Biol 2015;36:9537-44. [DOI: 10.1007/s13277-015-3668-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
165 Yang K, Lu L, Liu H, Wang X, Gao Y, Yang L, Li Y, Su M, Jin M, Khan S. A comprehensive update on early gastric cancer: defining terms, etiology, and alarming risk factors. Expert Rev Gastroenterol Hepatol 2021;15:255-73. [PMID: 33121300 DOI: 10.1080/17474124.2021.1845140] [Reference Citation Analysis]
166 Jiao S, Li N, Cai S, Guo H, Wen Y. Inhibition of CYFIP2 promotes gastric cancer cell proliferation and chemoresistance to 5-fluorouracil through activation of the Akt signaling pathway. Oncol Lett 2017;13:2133-40. [PMID: 28454373 DOI: 10.3892/ol.2017.5743] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
167 Gunathilake M, Lee J, Choi IJ, Kim YI, Yoon J, Sul WJ, Kim JF, Kim J. Alterations in Gastric Microbial Communities Are Associated with Risk of Gastric Cancer in a Korean Population: A Case-Control Study.Cancers (Basel). 2020;12. [PMID: 32937864 DOI: 10.3390/cancers12092619] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
168 Matsunari O, Miftahussurur M, Shiota S, Suzuki R, Vilaichone RK, Uchida T, Ratanachu-ek T, Tshering L, Mahachai V, Yamaoka Y. Rare Helicobacter pylori Virulence Genotypes in Bhutan. Sci Rep 2016;6:22584. [PMID: 26931643 DOI: 10.1038/srep22584] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
169 Carvalho CE, Mccormick TM, Carvalho PC, Fischer JDSDG, Aquino PFD, Bravo Neto GP, Carvalho MDGDC. Considerations about gastric cancer proteomics. Rev Col Bras Cir 2016;43:395-7. [DOI: 10.1590/0100-69912016005016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
170 Mesic A, Rogar M, Hudler P, Bilalovic N, Eminovic I, Komel R. Characterization and risk association of polymorphisms in Aurora kinases A, B and C with genetic susceptibility to gastric cancer development. BMC Cancer 2019;19:919. [PMID: 31521144 DOI: 10.1186/s12885-019-6133-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
171 Anauate AC, Leal MF, Wisnieski F, Santos LC, Gigek CO, Chen ES, Calcagno DQ, Assumpção PP, Demachki S, Arasaki CH, Artigiani R, Rasmussen LT, Payão SM, Burbano RR, C Smith MA. Analysis of 8q24.21 miRNA cluster expression and copy number variation in gastric cancer. Future Med Chem 2019;11:947-58. [PMID: 31141411 DOI: 10.4155/fmc-2018-0477] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
172 Haghi A, Azimi H, Rahimi R. A Comprehensive Review on Pharmacotherapeutics of Three Phytochemicals, Curcumin, Quercetin, and Allicin, in the Treatment of Gastric Cancer. J Gastrointest Canc 2017;48:314-20. [DOI: 10.1007/s12029-017-9997-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 6.8] [Reference Citation Analysis]
173 Kalantari E, Asadi Lari MH, Roudi R, Korourian A, Madjd Z. Lgr5High/DCLK1High phenotype is more common in early stage and intestinal subtypes of gastric carcinomas. CBM 2017;20:563-73. [DOI: 10.3233/cbm-170383] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
174 Zagari RM, Romano M, Ojetti V, Stockbrugger R, Gullini S, Annibale B, Farinati F, Ierardi E, Maconi G, Rugge M, Calabrese C, Di Mario F, Luzza F, Pretolani S, Savio A, Gasbarrini G, Caselli M. Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015. Dig Liver Dis. 2015;47:903-912. [PMID: 26253555 DOI: 10.1016/j.dld.2015.06.010] [Cited by in Crossref: 70] [Cited by in F6Publishing: 68] [Article Influence: 10.0] [Reference Citation Analysis]
175 Zhang Y, Wu H, Yang F, Ning J, Li M, Zhao C, Zhong S, Gu K, Wang H. Prognostic Value of the Expression of DNA Repair-Related Biomarkers Mediated by Alcohol in Gastric Cancer Patients. Am J Pathol 2018;188:367-77. [PMID: 29331492 DOI: 10.1016/j.ajpath.2017.10.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
176 Luo D, Ni Q, Ji A, Gu W, Wu J, Jiang C. Dehydroabietic Acid Derivative QC4 Induces Gastric Cancer Cell Death via Oncosis and Apoptosis. Biomed Res Int 2016;2016:2581061. [PMID: 27057539 DOI: 10.1155/2016/2581061] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
177 Choi YJ, Kim N, Jang W, Seo B, Oh S, Shin CM, Lee DH, Jung HC. Familial Clustering of Gastric Cancer: A Retrospective Study Based on the Number of First-Degree Relatives. Medicine (Baltimore) 2016;95:e3606. [PMID: 27196462 DOI: 10.1097/MD.0000000000003606] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
178 Shi D, Liu Y, Wu D, Hu X. Transfection of the Helicobacter pylori CagA gene alters MUC5AC expression in human gastric cancer cells. Oncol Lett 2018;15:5208-12. [PMID: 29552159 DOI: 10.3892/ol.2018.7960] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
179 Sulo P, Šipková B. DNA diagnostics for reliable and universal identification of Helicobacter pyloriWorld J Gastroenterol 2021; 27(41): 7100-7112 [PMID: 34887630 DOI: 10.3748/wjg.v27.i41.7100] [Reference Citation Analysis]
180 Waldum H, Mjønes P. Towards Understanding of Gastric Cancer Based upon Physiological Role of Gastrin and ECL Cells. Cancers (Basel) 2020;12:E3477. [PMID: 33266504 DOI: 10.3390/cancers12113477] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
181 Santos JC, Brianti MT, Almeida VR, Ortega MM, Fischer W, Haas R, Matheu A, Ribeiro ML. Helicobacter pylori infection modulates the expression of miRNAs associated with DNA mismatch repair pathway. Mol Carcinog. 2017;56:1372-1379. [PMID: 27862371 DOI: 10.1002/mc.22590] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
182 Zhao P, Lan F, Zhang H, Zeng G, Liu D. Down-regulation of KIF2A inhibits gastric cancer cell invasion via suppressing MT1-MMP. Clin Exp Pharmacol Physiol 2018;45:1010-8. [PMID: 29781531 DOI: 10.1111/1440-1681.12974] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
183 Liu Y, Feng Y, Gao Y, Hou R. Clinical benefits of combined chemotherapy with S-1, oxaliplatin, and docetaxel in advanced gastric cancer patients with palliative surgery. Onco Targets Ther 2016;9:1269-73. [PMID: 27095004 DOI: 10.2147/OTT.S99684] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
184 Deng Y, Sun Z, Wang L, Wang M, Yang J, Li G. Biosensor-based assay of exosome biomarker for early diagnosis of cancer. Front Med 2021. [PMID: 34570311 DOI: 10.1007/s11684-021-0884-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
185 Song X, Bi Y, Guo W. Long noncoding RNA PROX1-AS1 promotes tumor progression and aggressiveness by sponging miR-647 in gastric cancer. Minerva Med 2021;112:421-3. [PMID: 31726808 DOI: 10.23736/S0026-4806.19.06223-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
186 Zhang X, Qian Y, Li F, Bei S, Li M, Feng L. microRNA-9 selectively targets LMX1A to promote gastric cancer cell progression. Biochemical and Biophysical Research Communications 2018;505:405-12. [DOI: 10.1016/j.bbrc.2018.09.101] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
187 Wang Z, Zhan-sheng H. Catalpol inhibits migration and induces apoptosis in gastric cancer cells and in athymic nude mice. Biomedicine & Pharmacotherapy 2018;103:1708-19. [DOI: 10.1016/j.biopha.2018.03.094] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
188 Hudler P. Challenges of deciphering gastric cancer heterogeneity. World J Gastroenterol 2015; 21(37): 10510-10527 [PMID: 26457012 DOI: 10.3748/wjg.v21.i37.10510] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 33] [Article Influence: 5.1] [Reference Citation Analysis]
189 Gui Z, Zhao Z, Sun Q, Shao G, Huang J, Zhao W, Kuang Y. LncRNA FEZF1-AS1 Promotes Multi-Drug Resistance of Gastric Cancer Cells via Upregulating ATG5. Front Cell Dev Biol 2021;9:749129. [PMID: 34790665 DOI: 10.3389/fcell.2021.749129] [Reference Citation Analysis]
190 Kim BJ, Hong C. Role of transient receptor potential melastatin type 7 channel in gastric cancer. Integr Med Res. 2016;5:124-130. [PMID: 28462107 DOI: 10.1016/j.imr.2016.04.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
191 Li G, Yu S, Xu J, Zhang X, Ye J, Wang Z, He Y. The prognostic role of Helicobacter pylori in gastric cancer patients: A meta-analysis. Clin Res Hepatol Gastroenterol 2019;43:216-24. [PMID: 30361060 DOI: 10.1016/j.clinre.2018.08.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
192 Kanda M, Shimizu D, Tanaka H, Tanaka C, Kobayashi D, Hayashi M, Iwata N, Niwa Y, Yamada S, Fujii T, Sugimoto H, Murotani K, Fujiwara M, Kodera Y. Significance of SYT8 For the Detection, Prediction, and Treatment of Peritoneal Metastasis From Gastric Cancer. Ann Surg. 2018;267:495-503. [PMID: 28026832 DOI: 10.1097/sla.0000000000002096] [Cited by in Crossref: 43] [Cited by in F6Publishing: 29] [Article Influence: 14.3] [Reference Citation Analysis]
193 Zhang Z, Liu Y, Liu P, Yang L, Jiang X, Luo D, Yang D. Non-invasive detection of gastric cancer relevant d -amino acids with luminescent DNA/silver nanoclusters. Nanoscale 2017;9:19367-73. [DOI: 10.1039/c7nr07337b] [Cited by in Crossref: 30] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
194 Zhang XY, Zhang PY. Gastric cancer: somatic genetics as a guide to therapy. J Med Genet. 2016; Sep 8. [Epub ahead of print]. [PMID: 27609016 DOI: 10.1136/jmedgenet-2016-104171] [Cited by in Crossref: 29] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
195 Lianos GD, Mangano A, Cho WC, Roukos DH. From standard to new genome-based therapy of gastric cancer. Expert Review of Gastroenterology & Hepatology 2015;9:1023-6. [DOI: 10.1586/17474124.2015.1060856] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
196 Serpeloni JM, Specian AFL, Ribeiro DL, Tuttis K, Heredia-Vieira SC, Vilegas W, Martínez-López W, Varanda EA, de Syllos Cólus IM. Selective anticancer effects of Serjania marginata Casar. extract in gastric cells are mediated by antioxidant response. Environ Toxicol 2021;36:1544-56. [PMID: 33885224 DOI: 10.1002/tox.23151] [Reference Citation Analysis]
197 Guo Z, Zhou C, Zhou L, Wang Z, Zhu X, Mu X. Overexpression of DAPK1-mediated inhibition of IKKβ/CSN5/PD-L1 axis enhances natural killer cell killing ability and inhibits tumor immune evasion in gastric cancer. Cellular Immunology 2021. [DOI: 10.1016/j.cellimm.2021.104469] [Reference Citation Analysis]
198 Lin Y, Wu Z, Guo W, Li J. Gene mutations in gastric cancer: a review of recent next-generation sequencing studies. Tumour Biol. 2015;36:7385-7394. [PMID: 26364057 DOI: 10.1007/s13277-015-4002-1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
199 Liu K, Yang K, Wu B, Chen H, Chen X, Chen X, Jiang L, Ye F, He D, Lu Z. Tumor-Infiltrating Immune Cells Are Associated With Prognosis of Gastric Cancer. Medicine (Baltimore). 2015;94:e1631. [PMID: 26426650 DOI: 10.1097/md.0000000000001631] [Cited by in Crossref: 59] [Cited by in F6Publishing: 44] [Article Influence: 9.8] [Reference Citation Analysis]
200 Holleczek B, Schöttker B, Brenner H. Helicobacter pylori infection, chronic atrophic gastritis and risk of stomach and esophagus cancer: Results from the prospective population‐based ESTHER cohort study. Int J Cancer 2020;146:2773-83. [DOI: 10.1002/ijc.32610] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
201 Du S, Yang Z, Lu X, Yousuf S, Zhao M, Li W, Miao J, Wang X, Yu H, Zhu X, Chen H, Shi L, Xu E, Xia X, Guan W. Anoikis resistant gastric cancer cells promote angiogenesis and peritoneal metastasis through C/EBPβ-mediated PDGFB autocrine and paracrine signaling. Oncogene 2021. [PMID: 34341514 DOI: 10.1038/s41388-021-01988-y] [Reference Citation Analysis]
202 Menbari MN, Nasseri S, Menbari N, Mehdiabadi R, Alipur Y, Roshani D. The -160 (C>A) CDH1 Gene Promoter Polymorphism and Its Relationship with Survival of Patients with Gastric Cancer in Kurdistan. Asian Pac J Cancer Prev 2017;18:1561-5. [PMID: 28669168 DOI: 10.22034/APJCP.2017.18.6.1561] [Reference Citation Analysis]
203 Ren C, Chen H, Han C, Fu D, Wang D, Shen M. High expression of miR-16 and miR-451 predicating better prognosis in patients with gastric cancer. J Cancer Res Clin Oncol. 2016;142:2489-2496. [PMID: 27605261 DOI: 10.1007/s00432-016-2243-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
204 Wu J, Qin W, Wang Y, Sadik A, Liu J, Wang Y, Song P, Wang X, Sun K, Zeng J, Wang L. SPDEF is overexpressed in gastric cancer and triggers cell proliferation by forming a positive regulation loop with FoxM1. J Cell Biochem 2018;119:9042-54. [PMID: 30076647 DOI: 10.1002/jcb.27161] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
205 Song M, Camargo MC, Weinstein SJ, Best AF, Männistö S, Albanes D, Rabkin CS. Family history of cancer in first-degree relatives and risk of gastric cancer and its precursors in a Western population. Gastric Cancer 2018;21:729-37. [PMID: 29455268 DOI: 10.1007/s10120-018-0807-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
206 Hinsenkamp I, Schulz S, Roscher M, Suhr AM, Meyer B, Munteanu B, Fuchser J, Schoenberg SO, Ebert MP, Wängler B, Hopf C, Burgermeister E. Inhibition of Rho-Associated Kinase 1/2 Attenuates Tumor Growth in Murine Gastric Cancer. Neoplasia 2016;18:500-11. [PMID: 27566106 DOI: 10.1016/j.neo.2016.07.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
207 Liu X, Zhang J, Liu L, Jiang Y, Ji J, Yan R, Zhu Z, Yu Y. Protein arginine methyltransferase 5-mediated epigenetic silencing of IRX1 contributes to tumorigenicity and metastasis of gastric cancer. Biochim Biophys Acta Mol Basis Dis 2018;1864:2835-44. [PMID: 29802960 DOI: 10.1016/j.bbadis.2018.05.015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
208 Pucułek M, Machlowska J, Wierzbicki R, Baj J, Maciejewski R, Sitarz R. Helicobacter pylori associated factors in the development of gastric cancer with special reference to the early-onset subtype. Oncotarget 2018;9:31146-62. [PMID: 30123433 DOI: 10.18632/oncotarget.25757] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
209 Wang HL, Zhou R, Liu J, Chang Y, Liu S, Wang XB, Huang MF, Zhao Q. MicroRNA-196b inhibits late apoptosis of pancreatic cancer cells by targeting CADM1. Sci Rep 2017;7:11467. [PMID: 28904340 DOI: 10.1038/s41598-017-11248-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
210 Asghari A, Nowras T, Tavakoli T, Fakharian T, Razavi FE, Soltaninejad E, Naseri M. Association between rs4986790 and rs4986791 Polymorphisms in TLR4 with Colorectal Cancer Risk in Iranian Population. Russ J Genet 2021;57:740-4. [DOI: 10.1134/s1022795421060028] [Reference Citation Analysis]
211 Ramos MFKP, Ribeiro Júnior U, Viscondi JKY, Zilberstein B, Cecconello I, Eluf-Neto J. Risk factors associated with the development of gastric cancer - case-control study. Rev Assoc Med Bras (1992) 2018;64:611-9. [PMID: 30365663 DOI: 10.1590/1806-9282.64.07.611] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
212 Drici Ael-M, Moulessehoul S, Tifrit A, Diaf M, Turki DK, Bachir M, Tou A. Effect of IL-1β and IL-1RN polymorphisms in carcinogenesis of the gastric mucosa in patients infected with Helicobacter pylori in Algeria. Libyan J Med 2016;11:31576. [PMID: 27340011 DOI: 10.3402/ljm.v11.31576] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
213 Li L, Xing R, Cui J, Li W, Lu Y. Investigation of frequent somatic mutations of MTND5 gene in gastric cancer cell lines and tissues. Mitochondrial DNA B Resour 2018;3:1002-8. [PMID: 33474396 DOI: 10.1080/23802359.2018.1501287] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
214 Wang X, Guo J, Dai M, Wang T, Yang T, Xiao X, Tang Q, Zhang L, Jia L. PLOD2 increases resistance of gastric cancer cells to 5-fluorouracil by upregulating BCRP and inhibiting apoptosis.J Cancer. 2020;11:3467-3475. [PMID: 32284742 DOI: 10.7150/jca.41828] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
215 Quach DT, Ha DV, Hiyama T. The Endoscopic and Clinicopathological Characteristics of Early-onset Gastric Cancer in Vietnamese Patients. Asian Pac J Cancer Prev. 2018;19:1883-1886. [PMID: 30049355 DOI: 10.22034/apjcp.2018.19.7.1883] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
216 Torruella-Loran I, Ramirez Viña MK, Zapata-Contreras D, Muñoz X, Garcia-Ramallo E, Bonet C, Gonzalez CA, Sala N, Espinosa-Parrilla Y; EPIC gastric cancer working group. rs12416605:C>T in MIR938 associates with gastric cancer through affecting the regulation of the CXCL12 chemokine gene. Mol Genet Genomic Med 2019;7:e832. [PMID: 31273931 DOI: 10.1002/mgg3.832] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
217 Jiang Y, Chen C, Xie J, Wang W, Zha X, Lv W, Chen H, Hu Y, Li T, Yu J, Zhou Z, Xu Y, Li G. Radiomics signature of computed tomography imaging for prediction of survival and chemotherapeutic benefits in gastric cancer. EBioMedicine. 2018;36:171-182. [PMID: 30224313 DOI: 10.1016/j.ebiom.2018.09.007] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 13.8] [Reference Citation Analysis]
218 Beheshtizadeh M, Moslemi E. Analysis of G3BP1 and VEZT Expression in Gastric Cancer and Their Possible Correlation with Tumor Clinicopathological Factors. J Gastric Cancer 2017;17:43-51. [PMID: 28337362 DOI: 10.5230/jgc.2017.17.e5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
219 Li J, Zhang C, Wei J, Zheng P, Zhang H, Xie Y, Bai J, Zhu Z, Zhou K, Liang X, Xie Y, Qin T. Intratumoral and Peritumoral Radiomics of Contrast-Enhanced CT for Prediction of Disease-Free Survival and Chemotherapy Response in Stage II/III Gastric Cancer. Front Oncol 2020;10:552270. [PMID: 33425719 DOI: 10.3389/fonc.2020.552270] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
220 Martinez VD, Enfield KSS, Rowbotham DA, Lam WL. An atlas of gastric PIWI-interacting RNA transcriptomes and their utility for identifying signatures of gastric cancer recurrence. Gastric Cancer 2016;19:660-5. [PMID: 25779424 DOI: 10.1007/s10120-015-0487-y] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 5.9] [Reference Citation Analysis]
221 Sandoval-Bórquez A, Saavedra K, Carrasco-Avino G, Garcia-Bloj B, Fry J, Wichmann I, Corvalán AH. Noncoding Genomics in Gastric Cancer and the Gastric Precancerous Cascade: Pathogenesis and Biomarkers. Dis Markers 2015;2015:503762. [PMID: 26379360 DOI: 10.1155/2015/503762] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
222 Sheibani S, Mahmoudian RA, Abbaszadegan MR, Chamani J, Memar B, Gholamin M. Expression analysis of matrix metalloproteinase-13 in human gastric cancer in the presence of Helicobacter Pylori infection. Cancer Biomark 2017;18:349-56. [PMID: 28128735 DOI: 10.3233/CBM-160127] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
223 Yuan K, Ye J, Liu Z, Ren Y, He W, Xu J, He Y, Yuan Y. Complement C3 overexpression activates JAK2/STAT3 pathway and correlates with gastric cancer progression. J Exp Clin Cancer Res 2020;39:9. [PMID: 31928530 DOI: 10.1186/s13046-019-1514-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
224 Yu B, Xie J. Identifying therapeutic targets in gastric cancer: the current status and future direction. Acta Biochim Biophys Sin (Shanghai) 2016;48:90-6. [PMID: 26373844 DOI: 10.1093/abbs/gmv084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 0.1] [Reference Citation Analysis]
225 Xing L, Guo H, Zheng D, Liu J, Zhou B, Li Y, Wang N, Zhao P, Liang Y, Wu W, Li G. Gastric cancer is associated with a high rate of microsatellite instability versus chronic gastritis: A retrospective study. Revista Romana de Medicina de Laborator 2020;28:57-65. [DOI: 10.2478/rrlm-2020-0006] [Reference Citation Analysis]
226 Colvin H, Yamamoto K, Wada N, Mori M. Hereditary Gastric Cancer Syndromes. Surg Oncol Clin N Am 2015;24:765-77. [PMID: 26363540 DOI: 10.1016/j.soc.2015.06.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
227 Zhang X, Shi D, Liu YP, Chen WJ, Wu D. Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells. Yonsei Med J 2018;59:633-42. [PMID: 29869461 DOI: 10.3349/ymj.2018.59.5.633] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
228 Park S, Lee J, Kim YH, Park J, Shin JW, Nam S. Clinical relevance and molecular phenotypes in gastric cancer, of TP53 mutations and gene expressions, in combination with other gene mutations. Sci Rep. 2016;6:34822. [PMID: 27708434 DOI: 10.1038/srep34822] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
229 Sahoo AK, Sailapu SK, Dutta D, Banerjee S, Ghosh SS, Chattopadhyay A. DNA-Templated Single Thermal Cycle Based Synthesis of Highly Luminescent Au Nanoclusters for Probing Gene Expression. ACS Sustainable Chem Eng 2018;6:2142-51. [DOI: 10.1021/acssuschemeng.7b03568] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
230 Zhang J, Zhou Y, Huang T, Wu F, Pan Y, Dong Y, Wang Y, Chan AKY, Liu L, Kwan JSH, Cheung AHK, Wong CC, Lo AKF, Cheng ASL, Yu J, Lo KW, Kang W, To KF. FGF18, a prominent player in FGF signaling, promotes gastric tumorigenesis through autocrine manner and is negatively regulated by miR-590-5p. Oncogene 2019;38:33-46. [PMID: 30082912 DOI: 10.1038/s41388-018-0430-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
231 Link A, Kupcinskas J. MicroRNAs as non-invasive diagnostic biomarkers for gastric cancer: Current insights and future perspectives. World J Gastroenterol 2018; 24(30): 3313-3329 [PMID: 30122873 DOI: 10.3748/wjg.v24.i30.3313] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 54] [Article Influence: 12.8] [Reference Citation Analysis]